USA: Nonprescription Drug Product With an Additional Condition for Nonprescription Use
Updated on : 02-02-2025
| In accordance with the memorandum of 20 January 2025, from the President, entitled ''Regulatory Freeze Pending Review,'' the effective date of the final rule, (notified as G/TBT/N/USA/1889/Add.2) entitled Nonprescription Drug Product With an Additional Condition for Nonprescription Use,'' (ACNU) is delayed until 21 March 2025.>The effective date for the final rule published 26 December 2024, (89 FR 105288), is delayed until 21 March 2025.90 Federal Register (FR) 8173, 27 January 2025; Title 21 Code of Federal Regulations (CFR) Parts 201 and 314 https://www.govinfo.gov/content/pkg/FR-2025-01-27/html/2025-01840.htmhttps://www.govinfo.gov/content/pkg/FR-2025-01-27/pdf/2025-01840.pdfThis action and previous actions notified under the symbol G/TBT/N/USA/1889 are identified by Docket Number FDA-2021-N-0862. The Docket Folder is available from Regulations.gov at https://www.regulations.gov/docket/FDA-2021-N-0862/document and provides access to primary and supporting documents as well as comments received. Documents are also accessible from Regulations.gov by searching the Docket Number. |
Most Recent Announcements
Search All Announcements
National Enquiry Point for Trade
Click here to submit queryMember Area
Search this Site
Contents
Download Trade Portal Apps
Search Trade Information
Import Resources
Feature Information for Entrepreneur
Follow Us
Upcoming Events